Target Validation Information
Target ID T11211
Target Name Androgen receptor
Target Type
Successful
Drug Potency against Target RU-59063 Drug Info Ki = 2.23 nM [525861]
6,11-dihydrothiochromeno[4,3-b]indol-8-ol Drug Info IC50 = 4500 nM [528123]
1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane Drug Info IC50 = 163 nM [528558]
ZANOTERONE Drug Info Ki = 2200 nM [525925]
Mibolerone Drug Info Ki = 0.75 nM [525861]
11-methyl-6,11-dihydro-5H-benzo[a]carbazol-9-ol Drug Info IC50 = 30 nM [528123]
ZANOTERONE Drug Info Ki = 2000 nM [527548]
References
Ref 525861J Med Chem. 2000 Aug 24;43(17):3344-7.Design, synthesis, and pharmacological characterization of 4-[4, 4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]- 2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand.
Ref 528123Bioorg Med Chem Lett. 2006 Jun 15;16(12):3233-7. Epub 2006 Apr 5.Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
Ref 528558J Med Chem. 2006 Dec 14;49(25):7366-72.Identification of the brominated flame retardant 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane as an androgen agonist.
Ref 525925J Med Chem. 2000 Nov 30;43(24):4629-35.Chiral derivatives of 2-cyclohexylideneperhydro-4,7-methanoindenes, a novel class of nonsteroidal androgen receptor ligand: synthesis, X-ray analysis, and biological activity.
Ref 525861J Med Chem. 2000 Aug 24;43(17):3344-7.Design, synthesis, and pharmacological characterization of 4-[4, 4-dimethyl-3-(4-hydroxybutyl)-5-oxo-2-thioxo-1-imidazolidinyl]- 2-iodobenzonitrile as a high-affinity nonsteroidal androgen receptor ligand.
Ref 528123Bioorg Med Chem Lett. 2006 Jun 15;16(12):3233-7. Epub 2006 Apr 5.Discovery of indole-containing tetracycles as a new scaffold for androgen receptor ligands.
Ref 527548J Med Chem. 1992 May 15;35(10):1663-70.Antiandrogenic steroidal sulfonyl heterocycles. Utility of electrostatic complementarity in defining bioisosteric sulfonyl heterocycles.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.